Literature DB >> 28552026

Mental health clinicians' beliefs about the causes of psychosis: Differences between professions and relationship to treatment preferences.

Lucy Carter1,2, John Read3, Melissa Pyle2, Heather Law2, Anthony P Morrison1,2.   

Abstract

BACKGROUND: Previous evidence suggests that how an individual conceptualises the cause of a health problem can impact on subsequent perceptions and behaviour. AIMS: This study explored the beliefs about the causes of psychosis in a group of mental health professionals. The study also sought to examine the relationship between causal beliefs and the perceived helpfulness of different treatments.
METHODS: A total of 219 clinicians completed a questionnaire about the provision of cognitive behavioural therapy (CBT) and antipsychotic medication for their clients who were experiencing psychosis and their opinions about the helpfulness of these treatments. Causal beliefs were also assessed. RESULTS AND
CONCLUSIONS: Clients were twice as likely to be offered medication compared to CBT. Clinicians held a multifactorial model of aetiology, but were more likely to endorse psychosocial causes than biological factors. Clinicians with psychosocial beliefs were more likely to rate CBT as effective, whereas those with biological models were more likely to endorse the helpfulness of medication. Clinicians adopt a multi-causal approach when conceptualising the aetiology of psychosis and these beliefs were related to opinions about the helpfulness of treatment. Beliefs about the aetiology of their client's experiences could blind clinicians to the benefits of offering different approaches.

Entities:  

Keywords:  Causal beliefs; antipsychotic medication; clinician survey; cognitive behavioural therapy; mental health; treatment preference

Mesh:

Substances:

Year:  2017        PMID: 28552026     DOI: 10.1177/0020764017709849

Source DB:  PubMed          Journal:  Int J Soc Psychiatry        ISSN: 0020-7640


  1 in total

1.  Clinicians' views of treatment types for first episode psychosis delivered in a randomised controlled trial (MAPS).

Authors:  Byrne Re; Reeve S; Bird Jc; Jones W; Shiers D; Morrison Ap; Pyle M; Peters S
Journal:  EClinicalMedicine       Date:  2020-07-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.